• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫西拉坦在无尿儿童及血液透析期间的药代动力学

Pharmacokinetics of moxalactam in anuric children and during hemodialysis.

作者信息

Kaplan S L, Berry P L, Mason E O, Kramer W G

出版信息

Pediatr Pharmacol (New York). 1983;3(1):29-36.

PMID:6646877
Abstract

Pharmacokinetics of moxalactam were determined in children with chronic renal failure during a 4-hour hemodialysis or an interdialytic period following a 50 mg/kg dose. Mean elimination half-life during dialysis was 3.9 hours compared to 12.9 hours during the interdialytic period. Mean clearance of moxalactam was 86 ml/minute during hemodialysis and 25 ml/minute between dialysis. Mean dialyzer clearance of moxalactam was 45 ml/minute. The mean fraction of moxalactam removed during a 4-hour hemodialysis was 18% in nine children. In anuric children, a 50 mg/kg dose of moxalactam should be given every 48 hours in an interdialytic period and a 25 mg/kg dose given after each dialysis.

摘要

对慢性肾衰竭儿童在接受50mg/kg剂量治疗后,于4小时血液透析期间或透析间期测定了拉氧头孢的药代动力学。透析期间的平均消除半衰期为3.9小时,而透析间期为12.9小时。血液透析期间拉氧头孢的平均清除率为86ml/分钟,透析间期为25ml/分钟。拉氧头孢的平均透析器清除率为45ml/分钟。9名儿童在4小时血液透析期间拉氧头孢的平均清除分数为18%。对于无尿儿童,在透析间期应每48小时给予50mg/kg剂量的拉氧头孢,每次透析后给予25mg/kg剂量。

相似文献

1
Pharmacokinetics of moxalactam in anuric children and during hemodialysis.莫西拉坦在无尿儿童及血液透析期间的药代动力学
Pediatr Pharmacol (New York). 1983;3(1):29-36.
2
[Pharmacokinetics of moxalactam in adults].[成人莫西拉坦的药代动力学]
Sem Hop. 1983 Jun 30;59(26):1963-7.
3
The effect of hemodialysis on piperacillin pharmacokinetics.血液透析对哌拉西林药代动力学的影响。
Int J Clin Pharmacol Ther Toxicol. 1986 Dec;24(12):680-4.
4
Pharmacokinetics of vancomycin when administered during high flux hemodialysis.高通量血液透析期间给予万古霉素的药代动力学。
Clin Nephrol. 1998 Jul;50(1):51-5.
5
Effect of hemodialysis on ceftazidime pharmacokinetics.血液透析对头孢他啶药代动力学的影响。
Clin Nephrol. 1985 Sep;24(3):142-6.
6
[Pharmacokinetics of zidovudine (AZT) and its metabolite (G-AZT) in healthy subjects and in patients with kidney failure].齐多夫定(AZT)及其代谢产物(G-AZT)在健康受试者和肾衰竭患者中的药代动力学
Therapie. 1989 Nov-Dec;44(6):401-4.
7
Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.去羟肌苷在肾功能正常或慢性肾衰竭的HIV血清阳性患者中的处置:血液透析和持续性非卧床腹膜透析的影响
Clin Pharmacol Ther. 1996 Nov;60(5):535-42. doi: 10.1016/S0009-9236(96)90149-6.
8
Moxalactam pharmacokinetics during hemodialysis.血液透析期间的头孢氧哌唑药代动力学。
Antimicrob Agents Chemother. 1981 Apr;19(4):575-7. doi: 10.1128/AAC.19.4.575.
9
Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.肾功能衰竭患者及血液透析期间莫西拉坦的药代动力学
Antimicrob Agents Chemother. 1981 Sep;20(3):398-400. doi: 10.1128/AAC.20.3.398.
10
Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.来那度胺在不同程度肾功能损害受试者及血液透析受试者中的药代动力学。
J Clin Pharmacol. 2007 Dec;47(12):1466-75. doi: 10.1177/0091270007309563. Epub 2007 Oct 22.